Aclaris Therapeutics, Inc.

PA · United States · Reporting entity ID 100000216808

Total reported 2019–2025

$10.8M

#469 of 2,960 reporting companies — 0% of all reported industry payments

$681K in general payments across 3,236 records, plus $10.1M in research funding across 1,289 records.

How it breaks down

General payments $681,305

Research funding $10,079,021

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.